Cargando…
Efficacy and Safety of Tramadol Hydrochloride Twice-Daily Sustained-Release Bilayer Tablets with an Immediate-Release Component for Chronic Pain Associated with Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled, Treatment-Withdrawal Study
BACKGROUND AND OBJECTIVES: Knee osteoarthritis pain is a chronic form of pain for which conventional non-steroidal anti-inflammatory drugs may provide insufficient analgesia. Twice-daily tramadol hydrochloride (65% sustained-release/35% immediate-release) bilayer tablets are a novel formulation of t...
Autores principales: | Kawai, Shinichi, Sobajima, Satoshi, Jinnouchi, Masashi, Nakano, Hideshi, Ohtani, Hideaki, Sakata, Mineo, Adachi, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106645/ https://www.ncbi.nlm.nih.gov/pubmed/35435639 http://dx.doi.org/10.1007/s40261-022-01139-5 |
Ejemplares similares
-
Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride
por: Momin, Munira M., et al.
Publicado: (2015) -
Comparative bioequivalence studies of tramadol hydrochloride sustained-release 200 mg tablets
por: Khandave, Suhas S, et al.
Publicado: (2010) -
Formulation Optimization of Hydrodynamically Balanced Oral Controlled Release Bioadhesive Tablets of Tramadol Hydrochloride
por: Singh, Bhupinder, et al.
Publicado: (2010) -
Newly developed controlled release subcutaneous formulation for tramadol hydrochloride
por: Mabrouk, Mostafa, et al.
Publicado: (2018) -
High-Amylose Sodium Carboxymethyl Starch Matrices: Development and Characterization of Tramadol Hydrochloride Sustained-Release Tablets for Oral Administration
por: Nabais, Teresa, et al.
Publicado: (2014)